When a serious illness enters a family's life, there are many questions to ask and decisions to make. It is important to answer these questions quickly. The process can seem overwhelming. However, hospice care can be a wonderful resource for information about symptom management and comfort care. Hospice care professionals are available to help assess goals, pain management and care options during the decision-making process.
Are your symptoms minimal or moderate? Are these symptoms just starting to affect your life? If you want to continue treatment but also need comfort and symptom management, palliative care (often called comfort care) maybe an option. Palliative care is patient and family-centered care that optimizes quality of life by anticipating, preventing and treating suffering. Palliative care specialists address the physical, intellectual, emotional, social, and spiritual needs of patients and families, making sure they have access to all the information about the disease progression and the choices ahead. A patient can receive palliative care in conjunction with other treatments or therapies.
To view the multimedia release go to:
http://www.multivu.com/players/English/7429131-moments-of-life-by-hospice/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Christina Nicols, senior vice president and director of strategic planning and research at Hager Sharp, was named the Washington Women in Public Relations’ (WWPR) 2015 Washington PR Woman of the Year Friday in a ceremony honoring top public relations executives and celebrating women in communications.
Nicols was one of three public relations professionals chosen as an honoree for the 26th annual award. The other finalists were Carrie Fox, president of C. Fox Communications, and Lisa Throckmorton, chief operations officer at SpeakerBox Communications. The three finalists represent women who have led some of the most influential communications campaigns in the District and across the country.
“This is a phenomenal honor and I am humbled to be surrounded by such exemplary leaders in the field who are dedicated to mentoring and supporting the next generation of public relations professionals,” said Nicols. “It is a special privilege to join the ranks of previous PR Woman of the Year recipients including Hager Sharp’s own cofounders Susan Hager and Marcia Sharp, as well as our CEO Jennifer Wayman and executive vice president Debra Silimeo.”
Nicols was presented the award by Silimeo, the 2010 PR Woman of the Year, at Friday’s luncheon.
To view the multimedia release go to:
http://www.multivu.com/players/English/7695751-2015-wwpr-woman-of-the-year-award/
Buxton, the industry leader in customer analytics, is pleased to announce the launch of the Buxton Analytics Platform. The new cross-functional, mobile-friendly platform provides users with the combination of analytics tools relevant to their professional roles and unites organizations with a centralized view of their customers. Included in the platform is an upgrade to the company’s proprietary real estate tool, SCOUT.
“This cutting-edge platform is the future of the customer analytics industry,” said Tom Buxton, founder and CEO of Buxton. “With applications tailored to the needs of executives, analysts, real estate and marketing professionals, the platform truly unites organizations with a central view of their most important asset: customers. Buxton’s continued investment in new applications for the platform will fuel a constant stream of innovative analytics products designed to provide our clients with the answers they need to grow their organizations.”
The customizable platform is home to a growing collection of integrated, user friendly applications. SCOUT, Buxton’s industry-leading analytical mapping and management tool, is the banner application and now boasts an enhanced interface and functionality.
To view the multimedia release go to:
http://www.multivu.com/players/English/7649451-buxton-analytics-platform-launches/
Nuelle™, a sexual wellness and intimate care company focused on delivering groundbreaking solutions made specifically for women, announces today its Indiegogo campaign to raise awareness and funding for the company’s first product launch Fiera® Arouser for Her™.
In the US, roughly 46% of all American women, aged 18 – 70 have a sexual concern. Among committed couples, intimacy is important for both the health of the relationship and personal wellbeing. Sex, however, is often a tough subject to broach with partners, health care professionals and friends alike. Through its partnership with Indiegogo, Nuelle aims to normalize the conversation about women’s sexual wellbeing and the impact on quality of life, while educating couples about Fiera® Arouser for Her™ and its proven technology to scientifically enhance arousal and desire, naturally.
Co-created with women and healthcare professionals to bring back excitement to connect sexually with her partner, Nuelle’s Fiera® Arouser for Her™ is the first wearable intimacy enhancer used in advance of a sexual experience that is proven to ignite arousal and increase desire among women. In a study (after four weeks of using Fiera), 87% of women said they felt “in the mood” for sex and 83% enjoyed engaging in sex.*
To view the multimedia release go to:
http://www.multivu.com/players/English/7750851-nuelle-indiegogo-fiera-arouser-for-her/
Cutanea Life Sciences, Inc. (CLS), an emerging U.S. prescription product development company, formally unveiled its new digital presence, www.cutanea.com, to the dermatology community in conjunction with this winter’s annual gathering of dermatologists from the U.S and around the world. CLS has a stream of innovative product candidates in different stages of development that cover an array of skin conditions, including acne, rosacea, psoriasis and warts caused by human papillomavirus (HPV).
CLS’s new digital presence demonstrates the company’s intent to change the way that customers think about a valued dermatology partner. CLS believes that it can make an impact in the current state of dermatology practice through its commitment to focus on unmet and underserved patient needs. In turn this will help medical professionals optimize their practice time through CLS products and services.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743651-cutanea-life-sciences-dermatology/
Millennium Systems International, creators of Millennium and Meevo salon & spa software, have been busy working on a new initiative to showcase the deep connections consumers have with their hairstylists. “It’s so important to bring to light and recognize the deep connections that we have with our hairstylist,” said Millennium’s Marketing Director, Jen Martinelli. “I personally have been through proms, a wedding day, my daughter and son’s first haircut; all with my hair stylist by my side.”
The campaign starts with a grassroots effort by interviewing real people and real experiences in salons. Its purpose is to bring awareness to everyone, everywhere that beauty professionals play a very significant role in all of our lives. Happy moments, sad moments, and even in moments of feeling lost or confused, hairstylists are the consistent rock making us look and feel beautiful, confident, ready to take on the world. “Confidence is everything. It can mean landing a job, or picking up the pieces after a tragedy, or fighting through an illness,” continues Jen Martinelli. “You can’t buy confidence. Beauty professionals everywhere are making our lives more beautiful… in every sense of that word.”
Millennium Systems International has released its first video of the campaign today and it’s promising to be a tearjerker for everyone. One interviewee talks about the comfort she received from her hair stylist, “when my grandson passed away, when he was seven…. and I called her.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7753551-millennium-systems-dearhairstylist-campaign/
Employee benefit plan regulations pose unique, high risk questions for Plan Sponsors and effect the future well-being of all plan participants. EisnerAmper meets the demands of Plan Sponsors by providing audit, tax and advisory services to assist them with their fiduciary responsibilities in this often complex and technical area.
Why EisnerAmper?
• Partners and Directors who devote 100% of their time to employee benefit plans
• AICPA Employee Benefit Plan Audit Quality Center member firm
• Experience with over 400 annual benefit plan audits
• 2 reviews by the Department of Labor with no comments!
• Industry dedication and passion
While we know how essential it is for our professionals to be knowledgeable in the benefit plan industry, we believe it's also as important to share that information with our clients. Below are links to two of EisnerAmper’s benefit plan libraries.
To view the multimedia release go to:
http://www.multivu.com/players/English/7461932-eisneramper-employee-benefits/
ConnXus, a supplier diversity technology platform, today announced that it has closed $5 million in Series “A” funding, led by Techstars Ventures, Serious Change L.P. and Impact America Fund.
“This round of funding will significantly accelerate ConnXus’ long-term impact on generating sustainable and diverse supply chains,” said Rod Robinson, CEO and founder of ConnXus. “To date we’ve raised $10 million in investments, including participation from Techstars Ventures, CincyTech, Serious Change L.P., Impact America Fund, and several private angel investors.”
ConnXus’ cloud-based, supplier diversity sustainability dashboards open the door for procurement, supplier diversity, and supply chain professionals to access a wealth of global supply chain analytics. Robinson believes Techstars and the other investors are the right investors for the company to disrupt and add imperative value to the $10-billion supply chain and procurement software market.
To view the multimedia release go to:
http://www.multivu.com/players/English/7834951-connxus-five-million-series-a/
Sleep Inn, an all new construction brand and leader in the midscale lodging segment has revealed the latest evolution of its successful prototype. The concept builds upon the current prototype, which has demonstrated great appeal for its simply stylish aesthetic as well as its cost effectiveness to build and operate. The enhanced look and feel has evolved to meet the changing tastes and behaviors of travelers while still remaining cost neutral to today’s already efficient prototype. Leaders of the brand, which is franchised by Choice Hotels International, Inc. (NYSE: CHH), one of the world’s largest hotel companies, made the announcement during the Choice Hotels Annual Convention in Las Vegas attended by nearly 6,000 Choice Hotels franchisees and hospitality professionals.
To view the multimedia release go to:
http://www.multivu.com/players/English/7772451-choice-hotels-sleep-inn-prototype/
